aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Pathology Watch, founded with the mission to revolutionize dermatopathology, offers a user-friendly digital pathology solution tailored for dermatologists. The company aims to enhance patient outcomes by integrating advanced digital tools into dermatological practices, streamlining workflows, and improving diagnostic accuracy. Their primary product is a comprehensive digital pathology platform that seamlessly interfaces with electronic medical records (EMR), allowing for efficient and precise pathology services.
Notable affiliated individuals include Dr. Kelly Stankiewicz, Dr. Jeffrey R. Smith, and Dr. Jesse Jensen, who have endorsed the platform for its operational efficiency and utility in patient communication. Pathology Watch has achieved significant milestones in improving practice efficiency and patient care through its innovative digital solutions. The company's impact is evident in the enhanced operational workflows and improved diagnostic capabilities experienced by its users, positioning it as a leader in digital dermatopathology.
Operating Status
Active
Ownership Type(s)
Private
Main Product(s)
Digital Pathology
Technology
Telemedicine
Tags
Healthtech, SaaS
Model Types
Platform, Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
United States
When was Pathology Watch founded?
Pathology Watch was founded in 2018.
Where is Pathology Watch's headquarters located?
Pathology Watch's headquarters is located in Murray, US.
How many employees does Pathology Watch have?
Pathology Watch has 66 employees as of Feb 5, 2024.
How much has Pathology Watch raised to-date?
As of July 05, 2023, Pathology Watch has raised a total of $56.7M (USD) since Apr 18, 2023.
Add Comparison
Total Raised to Date
$56.7M
USD
Last Update Apr 18, 2023
Total Employees Over Time
66
As of Feb 2024
Pathology Watch Address
497 W 4800 S
suite 201
Murray,
84123
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts